wissenschaftliche publikationen 2010

Transcription

WIS S E NS C HAF TLIC HE
PUBLIK ATIONE N 2010
Auner V, Sehouli J, Oskay-Oezcelik G, Horvat R,
Speiser P, Zeillinger R.
ABC transporter gene expression in
benign and malignant ovarian tissue.
Gynecol Oncol. 2010 May;117(2):198-201
IF: 3,733
Bentz EK, Kenning M, Schneeberger C, Kolbus A,
Huber JC, Hefler LA, Tempfer CB
OCT-4 expression in follicular and luteal
phase endometrium: a pilot study.
Reprod Biol Endocrinol. 2010 Apr 22;8(1):38
IF: 2,077
Bentz EK*, Pils D*, Bilban M, Kaufmann U,
Hefler LA, Reinthaller A, Singer CF,
Huber JC, Horvat R, Tempfer CB.
Gene expression signatures of breast tissue before
and after cross-sex hormone therapy in
female-to-male transsexuals
* Equal contribution
Fert Steril. 2010;94:2688-96
IF: 3,970
Springer A, Fartacek R, Reck CA,
Horcher E, Bettelheim D.
Major complication after intrauterine
vesico-amniotic shunting.
Afr J Paediatr Surg. 2010 Sep-Dec;7(3):200-2
Li XB, Kasprian G, Hodge JC, Jiang XL,
Bettelheim D, Brugger PC, Prayer D.
Fetal ocular measurements by MRI.
Prenat Diagn. 2010 Nov;30(11):1064-71
IF: 2,152
Bettelheim D, Panzer S, Reesink HW, Csapo B,
Pessoa C, Guerra F, Wendel S, Calda P, Sprogøe U,
Dziegiel M, Aitokallio-Tallberg A, Koskinen S,
Kuosmanen M, Legler TJ, Stein W, Villa S, Villa MA,
Trespidi L, Acaia B, Vandenbussche FP, Brand A,
de Haas M, Kanhai HH, Gounder D, Flanagan P,
Donegan R, Parry E, Sefonte C, Skulstad SM,
Hervig T, Flesland Ø, Zupanska B, Uhrynowska M,
Lapaire O, Zhong XY, Holzgreve W.
Monitoring and treatment of anti-D in pregnancy.
Vox Sang. 2010 Aug 1;99(2):177-92
IF: 2,585
Gotic I, Schmidt WM, Biadasiewicz K, Leschnik M,
Spilka R, Braun J, Stewart CL, Foisner R.
Loss of LAP2 alpha delays satellite cell differentiation
and affects postnatal fiber-type determination.
Stem Cells. 2010 Mar 31;28(3):480-8
IF: 7,747
Gotic I, Leschnik M, Kolm U, Markovic M, Haubner BJ,
Biadasiewicz K, Metzler B, Stewart CL, Foisner R.
Lamina-associated polypeptide 2alpha loss impairs heart
function and stress response in mice.
Circ Res. 2010 Feb 5;106(2):346-53
IF: 9,214
178 | Universitätsklinik für Frauenheilkunde
Bodner K, Wierrani F, Grünberger W, Bodner-Adler B
Influence of the mode of delivery on maternal
and neonatal outcomes: a comparison between
elective cesarean section and planned vaginal
delivery in a low-risk obstetric population.
Arch Gynecol Obstet. 2010 May 27
IF: 0,912
Brunner A, Grimm C, Polterauer S, Hefler L,
Stani J, Dudek G, Horvat R.
Expression of epidermal growth factor receptor
and vascular endothelial growth factor in vaginal
squamous cell cancer.
Am J Obstet Gynecol 2010 Nov 17
IF: 3,278
Bodner K, Bodner-Adler B, Gruenberger W
Evaluation of the contraceptive efficacy, compliance and
satisfaction with the transdermal patch system Evra:
a comparison between adolescent and adult users
Arch Gynecol Obstet. 2010 Jan 29
IF: 0,912
Grimm C, Polterauer S, Zeillinger R,
Tong D, Heinze G, Wolf A, Natter C,
Reinthaller A, Hefler LA.
Two multidrug-resistance (ABCB1) gene polymorphisms as
prognostic parameters in women with ovarian cancer. Anticancer Res 2010;30:3487-91
IF: 1,428
Getoff N, Danielova I, Hartmann J, Schittl H,
Gerschpacher M, Ying S, Quint R, Huber JC
Metabolite Formation of 17α-Hydroxyprogesterone
as a Consequence of e-aq-Emission and
Progesterone Effect Regarding Cancer
In Vivo 2010 Sep-Oct;24(5):727-33
IF: 1,171
Eifler RL, Lind J, Falkenhagen D, Weber V,
Fischer MB, Zeillinger R.
Enrichment of circulating tumor cells from a large
blood volume using leukapheresis and elutriation:
Proof of concept.
Cytometry B Clin Cytom. 2010 Oct 15
IF: 1,727
Begovic H, Gatterer M, Pils S, Stani J, Wiener H, Joura E
A pilot study on L! capsid protein in
vulvar intraepithelial neoplasia.
Gebh Frauenh. 2010;70:424
IF: 0,354
Gatterer M, Pils S, Horvat R, Leodolter S, Joura E
Proline, glutamic acid and leucine rich
protein (PELP-1) is not a prognostic marker
for the epithelal ovarian cancer.
Gebh Frauenh. 2010;70:425
IF: 0,354
Gerschpacher M, Getoff N, Hartmann J, Schittl H,
Danielova I, Ying S, Huber JC, Quint RM.
Electron emission and product analysis of estrone:
progesterone interactions studied by experiments in vitro.
Gynecol Endocrinol. 2010; Early Online: 1-8
IF: 1,360
Getoff N, Schittl H, Gerschpacher M, Hartmann J,
Huber JC, Quint RM
17β-Estradiol Acting as an Electron Mediator:
Experiments In Vitro
In Vivo. 2010 Mar-Apr;24(2):173-8
IF: 1,171
Getoff N, Gerschpacher M, Hartmann J, Huber JC,
Schittl H, Quint RM
The 4-hydroxyestrone: Electron emission,
formation of secondary metabolites and
mechanisms of carcinogenesis.
J Photochem Photobiol B. 2010 Jan 21;98(1):20-4 IF: 1,871
Gschwantler-Kaulich D, Fink-Retter A,
Czerwenka K, Hudelist G, Kaulich A,
Kubista E, Singer CF
Differential expression pattern of estrogen receptors, aromatase, and sulfotransferase in breast cancer tissue and
corresponding lymph node metastases.
Tumor Biol. 2010 Dec 29
IF: 1,940
Tauber S, Jais A, Jeitler M, Haider S, Husa J,
Lindroos J, Knöfler M, Mayerhofer M,
Pehamberger H, Wagner O, Bilban M.
Transcriptome analysis of human cancer reveals a functional role of Heme Oxygenase-1 in tumor cell adhesion.
Mol Cancer. 2010 Jul 28;9(1):200
IF: 4,160
Bilban M, Tauber S, Haslinger P,
Pollheimer J, Saleh L, Pehamberger H,
Wagner O, Knöfler M.
Trophoblast invasion: assessment of cellular models using
gene expression signatures.
Placenta. 2010 Nov;31(11):989-96
IF: 2,767
Hefler LA, Polterauer S, Schneitter A,
Concin N, Hofstetter G, Bentz E, Leipold H,
Tempfer C, Reinthaller A.
Repeat surgery in patients with cervical cancer stage FIGO
IA1: a series of 156 cases and a review of the literature.
Anticancer Res. 2010;30:565-8
IF: 1,428
Hefler L, Grimm C, Tempfer C,
Reinthaller A.
Treatment with vaginal progesterone in women with lowgrade cervical dysplasia: a phase II trial.
Anticancer Res. 2010 Apr;30(4):1257-61
IF: 1,428
Zhang WH, Deneux-Tharaux C, Brocklehurst P,
Juszczak E, Joslin M, Alexander S;
EUPHRATES Group: Helmer H, Klein K
et al. Effect of a collector bag for Measurement of postpartum blood loss after vaginal delivery: cluster randomised
trial in 13 European countries.
BMJ 2010;340:c293
IF: 13,660
Universitätsklinik für Frauenheilkunde
| 179
Hofstetter G, Berger A, Fiegl H, Slade N, Zoric A, Holzer
B, Schuster E, Mobus VJ, Reimer D, Daxenbichler G,
Marth C, Zeimet AG, Concin N, Zeillinger R.
Alternative splicing of p53 and p73: the novel p53 splice
variant p53delta is an independent prognostic marker in
ovarian cancer.
Oncogene. 2010 Apr 1;29(13):1997-2004
IF: 7,135
Stoler MH, Vichnin MD, Ferenczy A, Ferris DG, Perez G,
Paavonen J, Joura EA, Djursing H, Sigurdsson K, Jefferson
L, Alvarez F, Sings HL, Lu S, James MK, Saah A, Haupt RM;
for the FUTURE I, II and III Investigators.
The accuracy of colposcopic biopsy: Analyses from the placebo arm of the Gardasil clinical trials.
Int J Cancer. 2010;May 20
IF: 4,722
Hudelist G, Huber A, Auer M, Knöfler M, Saleh L,
Hrachowitz C, Huber JC, Kubista E, Manavi M,
Bilban M, Singer CF.
Administration of betaHCG leads to dose-dependent
changes of gene expression signature of
endometriotic stromal cells.
Reprod Biomed Online. 2010 May;20(5):699-706 IF: 2,380
Huh W, Joura EA, Garland S,
Paavonen J, Ferris D, Sings H,
James M, Haupt R.
Impact of quadrivalent HPV 6/11/16/18 vaccine in women
who have undergone definitive therapy.
Gynecol Oncol 2010;117:394
IF: 3,733
Hudelist G, English J, Thomas A, Tinelli A,
Singer CF, Keckstein J.
Diagnostic accuracy of transvaginal ultrasound for noninvasive diagnosis of bowel endometriosis-a systematic
review and meta-analysis.
Ultrasound Obstet Gynecol. 2010 Oct 15
IF: 3,154
Khan K, Zamora J, Lamont RF, Van Geijn Hp H, Svare J,
Santos-Jorge C, Jacquemyn Y, Husslein P, Helmer H,
Dudenhausen J, Di Renzo GC, Roura LC, Beattie B.
Safety concerns for the use of calcium channel blockers
in pregnancy for the treatment of spontaneous preterm
labour and hypertension: a systematic review and metaregression analysis.
J Matern Fetal Neonatal Med. 2010;23(9):1030-8 IF: 1,362
Ault KA, Joura EA, Kjaer SK, Iversen OE, Wheeler CM,
Perez G, Brown DR, Koutsky LA, Garland SM, Olsson SE,
Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX,
Majewski S, Mu√±oz N, Sings HL, Harkins K,
Rutkowski MA, Haupt RM, Garner EI; for the
FUTURE I and II Study Group.
Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a
quadrivalent human papillomavirus vaccine.
Int J Cancer. 2010 Oct 14
IF: 4,722
Monsonego J, Cortes J, Greppe C, Hampl M,
Joura EA, Singer A.
Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16
and 18) vaccine.
Vaccine. 2010;28:8065-72
IF: 3,616
McCormack PL, Joura EA.
Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the
prevention ofpremalignant genital lesions, genital cancer
and genital warts in women.
Drugs. 2010;70:2449-74
IF: 4,732
Stoler MH, Vichnin MD, Ferenczy A, Ferris DG, Perez G,
Paavonen J, Joura EA, Djursing H, Sigurdsson K, Jefferson
L, Alvarez F, Sings HL, Lu S, James MK, Saah A, Haupt RM;
for the FUTURE I, II and III Investigators.
The accuracy of colposcopic biopsy: Analyses from the placebo arm of the Gardasil clinical trials.
Int J Cancer. 2010;May 20
IF: 4,722
Huh W, Joura E, Garland S, Paavonen J,
Ferris D, Sings H, James M, Haupt R.
Impact of quadrivalent HPV 6/11/16/18
vaccine in women who have undergone
definitive therapy.
Gynecol Oncol 2010;117:394
IF: 3,733
Kiss H, Petricevic L, Simhofer M, Husslein P.
Reducing preterm birth through a simple antenatal screenand-treat programme: a retrospective cohorte study.
Eur J Obstet Gyn R B 2010; 153:38-42
IF: 1,582
Klein K, Bancher-Todesca D,
Leipold H, Knöfler M, Haslinger P,
Handisurya A, Kautzky-Willer A, Worda C.
Retinol-Binding Protein 4 in Patients with
Gestational Diabetes Mellitus.
J Womens Health. 2010 Feb 15. 19(3):517-21
IF: 1,770
Köck K, Köck F, Klein K,
Bancher-Todesca D, Helmer H
Diabetes mellitus and the risk of preterm birth with
regard to the risk of spontaneous preterm birth.
J Matern Fetal Neonatal Med.
2010 Sep;23(9):1004-8
IF: 1,362
Winhofer Y, Handisurya A, Tura A,
Bittighofer C, Klein K, Schneider B,
Bieglmayer C, Wagner O, Pacini G,
Luger A, Kautzky Willer A
Osteocalcin is related to enhanced insulin secretion
in gestational diabetes.
Diabetes Care 2010;33:139-43
IF: 6,718
Klein K, Mailath-Pokorny M, Leipold H,
Krampl-Bettelheim E, Worda C.
Influence of gestational diabetes mellitus on weight
discrepancy in twin pregnancies.
Twin Res Hum Genet. 2010 Aug;13(4):393-7
IF: 1,994
Klein K, Worda C, Stammler-Safar M, Husslein P,
Gleicher N, Weghofer A.
Does fetal sex influence the risk of preterm delivery in dichorionic twin pregnancies after spontaneous conception?
Twin Res Hum Genet. 2010 Oct;13(5):495-500 IF: 1,994
Göbl C, Handisurya A, Klein K, Bozkurt L, Luger A,
Bancher-Todesca D, Kautzky-Willer A
Changes in Serum Lipis Levels during Pregnancy in Type 1
and Type 2 Diabetic Subjects.
Diabetes Care 2010;33:2071-3
IF: 6,718
Harris LK, Smith SD, Keogh RJ, Jones RL, Baker PN,
Knöfler M, Cartwright JE, Whitley GS, Aplin JD.
Trophoblast- and vascular smooth muscle cell-derived
MMP-12 mediates elastolysis during uterine spiral artery
remodeling.
Am J Pathol. 2010 Oct;177(4):2103-15
IF: 5,673
Königsberg R, Gneist M, Jahn-Kuch D, Pfeiler G,
Hager G, Hudec M,
Dittrich C, Zeillinger R. Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different
enrichment methods.
Cancer Lett. 2010 Jul;293(1):117-23.
IF: 3,741
FUTURE I/II Study Group, Dillner J, Kjaer SK, Wheeler CM,
Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G,
Brown DR, Koutsky LA, Tay EH, Garcia P, Ault KA, Garland
SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Lehtinen M, Steben M, Bosch FX, Joura EA,
Majewski S, Mu√±oz N, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Maansson R, Lu S, Vuocolo S,
Hesley TM, Barr E, Haupt R.
Four year efficacy of prophylactic human papillomavirus
quadrivalent vaccine against low grade cervical, vulvar,
and vaginal intraepithelial neoplasia andanogenital warts:
randomised controlled trial.
BMJ 2010 Jul 20;341:c3493
IF: 13,660
Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM,
Leodolter S, Joura EA, Ferris DG, Steben M, Brown DR, Elbasha EH, Paavonen J, Haupt RM; FUTURE I Investigators.
Incidence, duration, and reappearance of type-specific
cervical human papillomavirus infections in young women.
Cancer Epidem Biomark. 2010 Jun;19(6): 1585-94
IF: 4,310
Sanidas I, Kotoula V, Ritou E, Daans J, Lenz C,
Mairhofer M, Daniilidou M, Kolbus A, Kruft V,
Ponsaerts P, Nikolakaki E
The ratio of SRPK1/SRPK1a regulates erythroid differentiation in K562 leukaemic cells.
Biochim Biophys Acta. 2010 Dec;1803(12):1319-31
IF: 4,374
Preyer O, Brugger PC, Laml Th, Hanzal E,
Prayer D, Umek W
High resolution magnetic resonance imaging of urethral
anatomy in continent nulliparous pregnant women.
Eur J Radiol 2010, 4952-4955
IF: 2,645
Mailath-Pokorny M, Worda C,
Krampl-Bettelheim E,
Watzinger F, Brugger PC, Prayer D.
What does fetal MRI add to the prenatal ultrasound
diagnosis of facial clefts?
Ultrasound Obstet Gynecol. 2010 Oct;36(4):445-51
IF: 3,154
Messerschmidt A, Olischar M, Birnbacher R,
Weber M, Pollak A, Leitich H
Perinatal Outcome of Preterm Infants <1500 g after IVF
pregnancies compared with natural conception.
Arch Dis Child Fetal Neonatal Ed. 2010 May;95(3):F225-9
IF: 2,493
Mayerhofer K, Ott J, Nouri K, Stoegbauer L,
Fischer EM, Lipovac M, Promberger R, Huber JC
Laparoscopic ovarian tissue harvesting for cryopreservation:
an effective and safe procedure for fertility preservation.
Eur J Obstet Gynecol Reprod Biol. 2010 Sep;152(1):68-72
IF: 1,582
Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, HernandezAvila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay
EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson
SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX,
Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers
ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM,
Barr E, Haupt RM.
Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women. J Natl Cancer Inst.2010;102:325-32
IF: 14,069
Nouri K, Ott J, Krupitz B, Huber JC, Wenzl R
Family incidence of endometriosis in first-, second-, and
third-degree relatives: case-control study.
Reprod Biol Endocrin. 2010 Jul 11;8:85
IF: 2,077
Nouri K, Ott J, Huber JC, Fischer EM,
Stögbauer L, Tempfer CB
Reproductive outcome after hysteroscopic septoplasty in
patients with septate uterus--a retrospective cohort study
and systematic review of the literature.
Reprod Biol Endocrin. 2010 May 21;8:52
IF: 2,077
| 181
Nouri K, Bader Y, Helmy S, Ott J,
Jirecek S, Tempfer CB
Live birth after in vitro fertilization and single embryo transfer in a kidney transplant patient: a case report and review
of the literature
J Assist Reprod Gen, DOI 10.1007/
s10815-010-9521-5
IF: 1,359
Nouri K, Demmel M, Ott J, Promberger R,
Huber JC, Mayerhofer K
Villous mucinous cystadenoma of the appendix in a postmenopausal woman.
Journal of Society and Laparoscopic sourcen
2010;14(2):296-8
Obermayr E, Sanchez-Cabo F,
Tea MK, Singer CF, Krainer M,
Fischer MB, Sehouli J, Reinthaller A,
Horvat R, Heinze G, Tong D, Zeillinger R.
Assessment of a six gene panel for the molecular
detection of circulating tumor cells in the blood
of female cancer patients.
BMC Cancer. 2010 Dec 3;10(1):666
IF: 2,736
Ott J, Nouri K, Demmel M,
Zafraani S, Greilberger U,
Huber JC, Mayerhofer K.
Fourteen-year experience with laparoscopic ventrosuspension in patients with retroverted and retroflected uterus
and pelvic pain syndromes.
J Minim Invasive Gynecol. 2010 Nov-Dec;17(6):749-53
IF: 1,920
Promberger R, Ott J,
Kober F, Mikola B, Karik M,
Freissmuth M, Hermann M.
Intra- and postoperative parathyroid hormone-kinetics do
not advocate for autotransplantation of discolored parathyroid glands during thyroidectomy.
Thyroid 2010. Dec;20(12):1371-5
IF: 2,602
Ott J, van Trotsenburg M, Kaufmann U,
Schrögendorfer K, Haslik W, Huber JC, Wenzl R
Combined hysterectomy/salpingo-oophorectomy
and mastectomy is a safe and valuable procedure
for female-to-male transsexuals.
J Sex Med. 2010 Jun;7(6):2130-8
IF: 4,884
Ott J, Promberger R, Kober F, Neuhold N,
Tea M, Huber JC, Hermann M
Hashimoto‘s Thyroiditis Affects Symptom Load and Quality
of Life Unrelated to Hypothyroidism: A Prospective CaseControl Study in Women Undergoing Thyroidectomy for Benign Goiter. Thyroid. 2010 Dec 27
IF: 2,602
Ott J, Kaufmann U, Bentz EK, Huber JC, Tempfer CB.
Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy.
Fertil Steril. 2010 Mar 1;93(4):1267-72
IF: 3,970
Ott J, Poschalko G, Zeisler H
Severe early onset hemolysis, elevated liver enzyme, and
low platelet-syndrome in 2 subsequent pregnancies: case
report and review of the literature.
Arch Gynecol Obstet. 2010 Feb;281(2):265-8
IF: 0,912
Pfeiler G, Glatz C, Königsberg R, Geisendorfer T,
Fink-Retter A, Kubista E, Singer C, Seifert M
Vaginal estriol to overcome side effects of aromatase inhibitors in breast cancer patients.
Climacteric 2011 Jan; 1: 1-6
IF: 2,568
Pfeiler G, Hudelist G, Wülfing P, Mattsson B,
Königsberg R, Kubista E, Singer CF
Impact of AdipoR1 expression on
breast cancer development.
Gynecol Oncol. 2010 Apr;117(1):134-8.
IF: 3,733
Pietrowski D, Wiehle P, Sator M, Just A, Keck C
Regulation of the angiopoietin-2 gene by hCG in ovarian
cancer cell line OVCAR-3.
Horm Metab Res. 2010 May;42(5):328-33
IF: 2,686
Ott J, Aust S, Kurz C, Nouri K, Wirth S,
Elevated antithyroid peroxidase antibodies indicating
Hashimoto‘s thyroiditis are associated with the
treatment response in infertile women with
polycystic ovary syndrome.
Fertil Steril. 2010 Dec;94(7):2895-7
IF: 3,970
Pils D, Wittinger M, Petz M, Gugerell A, Gregor W,
Alfanz A, Horvat R, Braicu EI, Sehouli J, Zeillinger R,
Mikulits W, Krainer M.
BAMBI is overexpressed in ovarian cancer and co-translocates with Smads into the nucleus upon TGF-beta treatment.
IF: 3,733
Ott J, Kurz C, Nouri K, Wirth S, Vytiska-Binstorfer E,
Pregnancy outcome in women with polycystic ovary syndrome comparing the effects of laparoscopic ovarian drilling and clomiphene citrate stimulation in women pre-treated with metformin: a retrospective study.
Reprod Biol Endocrin. 2010 May 13;8:45
IF: 2,077
Sponheim J, Pollheimer J, Olsen T, Balogh J,
Hammarström C, Loos T, Kasprzycka M, Sørensen DR,
Nilsen HR, Küchler AM, Vatn MH, Haraldsen G.
Inflammatory bowel disease-associated interleukin-33 is
preferentially expressed in ulceration-associated myofibroblasts.
Am J Pathol. 2010 Dec;177(6):2804-15
IF: 5,673
Polterauer S, Grimm C, Hanzal E, Wenzl R,
Hefler L, Leodolter S, Husslein PW, Reinthaller A.
Surgical Skills Training – Results of a Prospective Trial.
Geburtsh Frauenh 2010, 70: 990-993
IF: 0,354
Polterauer S, Hefler L, Seebacher V, Rahhal J,
Tempfer C, Horvat R, Reinthaller A, Grimm C.
The impact of lymph node density on survival
of cervical cancer patient.
Br J Cancer 2010;103:613
IF: 4,346
Polterauer S, Grimm C, Seebacher V, Rahhal J,
Hefler-Frischmuth K, Tempfer C, Reinthaller A, Hefler L.
The inflammation based Glasgow Prognostic Score
predicts survival in patients with cervical cancer.
Int J Gynecol Cancer 2010;20:1052-7
IF: 2,179
Petru E, Reinthaller A, Angleitner-Boubenizek L,
Schauer C, Zeimet A, Dirschlmayer W, Medl M,
Stummvoll W, Sevelda P, Marth C.
Clinical consequences of the Calypso trial showing superiority of PEG-liposomal doxorubicin and carboplatin over paclitaxel and carboplatin in recurrent ovarian cancer: results
of an Austrian gynecologic oncologists‘ expert meeting.
Wien Klin Wochenschr. 2010 Nov;122(21-22):649-52
IF: 0,955
Harter P, Sehouli J, Reuss A, Hasenburg A, Scambia G, Cibula D, Mahner S, Vergote I, Reinthaller A, Burges A, Hanker
L, Pölcher M, Kurzeder C, Canzler U, Petry KU, Obermair A,
Petru E, Schmalfeldt B, Lorusso D, du Bois A.
Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer: The Multicenter Intergroup Study DESKTOP II. A Project of the AGO Kommission
OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO.
Int J Gynecol Cancer. 2011 Feb;21(2):289-295 IF: 2,179
Hofer H, Donnerer J, Sator K, Staufer K, Scherzer TM,
Dejaco C, Sator M, Kessler H, Ferenci P
Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy.
J Hepatol. 2010 Jun;52(6):812-6
IF: 7,818
Schlechta B, Wiedemann D, Kittinger C,
Jandrositz A, Bonaros N, Huber JC,
Preisegger KH, Kocher AA
Ex-vivo expanded umbilical cord blood stem cells
retain capacity for myocardial regeneration.
Circ J. 2010 Jan;74(1):188-94
IF: 2,692
Schmid M, Grimm C, Leipold H, Knöfler M,
Haslinger P, Egarter C.
A polymorphism of the corticotropin-releasing
hormone receptor 2 (CRHR2) and preterm birth.
Dis Markers. 2010;28(1):37-42
IF: 2,026
Schmid M, Kuessel L, Klein K, Metz V, Fischer G,
Krampl-Bettelheim E
First trimester fetal heart rate in mothers
with opioid addiction.
Addiction 2010,105(7):1265-8
IF: 3,842
Schmid M, Grimm Ch, Kuessel L, Wirth S,
Worda Ch, Kraml-Bettelheim E.
Lunar cycle and nuchal translucency in the first trimester
of pregnancy.
Biol Rhythm Res. 2010 Dec;41(6):497–502
IF: 0,731
Hefler-Frischmuth K, Seebacher V, Polterauer S,
Tempfer C, Reinthaller A, Hefler L.
The inflammation-based modified Glasgow Prognostic
Score in patients with vulvar cancer.
Eur J Obstet Gynecol Reprod Biol. 2010;149:102-5
IF: 1,582
Seebacher V, Polterauer S, Grimm C, Husslein H,
Leipold H, Hefler-Frischmuth K, Tempfer C,
Reinthaller A, Hefler L.
The prognostic value of plasma fibrinogen levels in patients
with endometrial cancer: a multi-centre trial.
Br J Cancer 2010;102:952-6
IF: 4,346
Brünner-Kubath C, Shabbir W, Saferding V, Wagner R,
Singer CF, Valent P, Berger W, Marian B,
Zielinski CC, Grusch M, Grunt TW.
The PI3 kinase/mTOR blocker NVP-BEZ235 overrides
resistance against irreversible ErbB inhibitors in breast
cancer cells.
Breast Cancer Res Treat. 2010 Nov 3
IF: 4,696
Metcalfe K, Lubinski J, Lynch HT, Ghadirian P, Foulkes WD,
Kim-Sing C, Neuhausen S, Tung N, Rosen B, Gronwald J,
Ainsworth P, Sweet K, Eisen A, Sun P, Narod SA; Hereditary
Breast Cancer Clinical Study Group. Collaborators: McKinnon W, Wood M, Saal H, Chudley A, Robidoux A, Provencher D, Lemire E, Tulman A, Llacuachaqui M, Gilchrist D,
Karlan B, Kurz R, Armel S, Demsky R, Panchal S, Couch F,
Manoukian S, Bordeleau L, Daly M, Cybulski C, Huzarski T,
Olapade O, Stoppa-Lyonnet D, Weitzel J, McLennan J, Meschino W, Pasini B, Singer C, Spiess C, Byrski T.
Family history of cancer and cancer risks in women with
BRCA1 or BRCA2 mutations.
J Natl Cancer Inst. 2010 Dec 15;102(24):1874-8 IF: 14,069
Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey
S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch
HT, saacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ,
Wang X, Lindor NM, Pankratz VS, Radice P, Manoukian S,
Peissel B, Zaffaroni D, Barile M, Viel A, Allavena A, Dall‘Olio
V, Peterlongo P, Szabo CI, Zikan M, Claes K, Poppe B, Foretova L, Mai PL, Greene MH, Rennert G, Lejbkowicz F, Glendon G, Ozcelik H, Andrulis IL; Ontario Cancer Genetics NetUniversitätsklinik für Frauenheilkunde
| 183
work, Thomassen M, Gerdes AM, Sunde L, Cruger D, Birk
Jensen U, Caligo M, Friedman E, Kaufman B, Laitman Y,
Milgrom R, Dubrovsky M, Cohen S, Borg A, Jernström H,
Lindblom A, Rantala J, Stenmark-Askmalm M, Melin B; SWEBRCA, Nathanson K, Domchek S, Jakubowska A, Lubinski J,
Huzarski T, Osorio A, Lasa A, Durán M, Tejada MI, Godino
J, Benitez J, Hamann U, Kriege M, Hoogerbrugge N, van der
Luijt RB, van Asperen CJ, Devilee P, Meijers-Heijboer EJ,
Blok MJ, Aalfs CM, Hogervorst F, Rookus M; HEBON, Cook
M, Oliver C, Frost D, Conroy D, Evans DG, Lalloo F, Pichert
G, Davidson R, Cole T, Cook J, Paterson J, Hodgson S, Morrison PJ, Porteous ME, Walker L, Kennedy MJ, Dorkins H,
Peock S; EMBRACE, Godwin AK, Stoppa-Lyonnet D, de
Pauw A, Mazoyer S, Bonadona V, Lasset C, Dreyfus H, Leroux D, Hardouin A, Berthet P, Faivre L; GEMO, Loustalot
C, Noguchi T, Sobol H, Rouleau E, Nogues C, Frénay M,
Vénat-Bouvet L; GEMO, Hopper JL, Daly MB, Terry MB, John
EM, Buys SS, Yassin Y, Miron A, Goldgar D; Breast Cancer
Family Registry, Singer CF, Dressler AC, GschwantlerKaulich D, Pfeiler G, Hansen TV, Jønson L, Agnarsson BA,
Kirchhoff T, Offit K, Devlin V, Dutra-Clarke A, Piedmonte M,
Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE,
Blank SV, Toland AE, Montagna M, Casella C, Imyanitov E,
Tihomirova L, Blanco I, Lazaro C, Ramus SJ, Sucheston L,
Karlan BY, Gross J, Schmutzler R, Wappenschmidt B, Engel
C, Meindl A, Lochmann M, Arnold N, Heidemann S, VaronMateeva R, Niederacher D, Sutter C, Deissler H, Gadzicki
D, Preisler-Adams S, Kast K, Schönbuchner I, Caldes T, de
la Hoya M, Aittomäki K, Nevanlinna H, Simard J, Spurdle
AB, Holland H, Chen X; kConFab, Platte R, Chenevix-Trench
G, Easton DF; CIMBA.
Common breast cancer susceptibility alleles and the risk
of breast cancer for BRCA1 and BRCA2 mutation carriers:
implications for risk prediction.
Cancer Res. 2010 Dec 1;70(23):9742-54
IF: 7,543
Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C,
Lesnick T, Ghoussaini M, Barrowdale D; EMBRACE, Peock
S, Cook M, Oliver C, Frost D, Eccles D, Evans DG, Eeles R,
Izatt L, Chu C, Douglas F, Paterson J, Stoppa-Lyonnet D,
Houdayer C, Mazoyer S, Giraud S, Lasset C, Remenieras
A, Caron O, Hardouin A, Berthet P; GEMO Study Collaborators, Hogervorst FB, Rookus MA, Jager A, van den Ouweland A, Hoogerbrugge N, van der Luijt RB, Meijers-Heijboer
H, Gómez García EB; HEBON, Devilee P, Vreeswijk MP,
Lubinski J, Jakubowska A, Gronwald J, Huzarski T, Byrski
T, Górski B, Cybulski C, Spurdle AB, Holland H; kConFab,
Goldgar DE, John EM, Hopper JL, Southey M, Buys SS, Daly
MB, Terry MB, Schmutzler RK, Wappenschmidt B, Engel C,
Meindl A, Preisler-Adams S, Arnold N, Niederacher D, Sutter C, Domchek SM, Nathanson KL, Rebbeck T, Blum JL,
Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil
J, Blank SV, Friedman E, Kaufman B, Laitman Y, Milgrom R,
Andrulis IL, Glendon G, Ozcelik H, Kirchhoff T, Vijai J, Gaudet MM, Altshuler D, Guiducci C; SWE-BRCA, Loman N,
Harbst K, Rantala J, Ehrencrona H, Gerdes AM, Thomassen
M, Sunde L, Peterlongo P, Manoukian S, Bonanni B, Viel A,
Radice P, Caldes T, de la Hoya M, Singer CF, Fink-Retter
A, Greene MH, Mai PL, Loud JT, Guidugli L, Lindor NM,
Hansen TV, Nielsen FC, Blanco I, Lazaro C, Garber J, Ramus
SJ, Gayther SA, Phelan C, Narod S, Szabo CI; MOD SQUAD,
Benitez J, Osorio A, Nevanlinna H, Heikkinen T, Caligo MA,
Beattie MS, Hamann U, Godwin AK, Montagna M, Casella
C, Neuhausen SL, Karlan BY, Tung N, Toland AE, Weitzel J,
Olopade O, Simard J, Soucy P, Rubinstein WS, Arason A,
Rennert G, Martin NG, Montgomery GW, Chang-Claude J,
Flesch-Janys D, Brauch H; GENICA, Severi G, Baglietto L,
Cox A, Cross SS, Miron P, Gerty SM, Tapper W, Yannoukakos D, Fountzilas G, Fasching PA, Beckmann MW, Dos
Santos Silva I, Peto J, Lambrechts D, Paridaens R, Rüdiger
T, Försti A, Winqvist R, Pylkäs K, Diasio RB, Lee AM, EckelPassow J, Vachon C, Blows F, Driver K, Dunning A, Pharoah
PP, Offit K, Pankratz VS, Hakonarson H, Chenevix-Trench
G, Easton DF, Couch FJ.
A locus on 19p13 modifies risk of breast cancer in BRCA1
mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.
Nat Genet. 2010 Oct;42(10):885-92
IF: 34,284
Walker LC, Fredericksen ZS, Wang X, Tarrell R, Pankratz VS,
Lindor NM, Beesley J, Healey S, Chen X; kConFab, StoppaLyonnet D, Tirapo C, Giraud S, Mazoyer S, Muller D, Fricker
JP, Delnatte C; GEMO Study ollaborators, Schmutzler RK,
Wappenschmidt B, Engel C, Schönbuchner I, Deissler H,
Meindl A, Hogervorst FB, Verheus M, Hooning MJ, van den
Ouweland AM, Nelen MR, Ausems MG, Aalfs CM, van Asperen CJ, Devilee P, Gerrits MM, Waisfisz Q; HEBON, Szabo
CI; ModSQuaD, Easton DF, Peock S, Cook M, Oliver CT,
Frost D, Harrington P, Evans DG, Lalloo F, Eeles R, Izatt
L, Chu C, Davidson R, Eccles D, Ong KR, Cook J; EMBRACE, Rebbeck T, Nathanson KL, Domchek SM, Singer CF,
Gschwantler-Kaulich D, Dressler AC, Pfeiler G, Godwin AK, Heikkinen T, Nevanlinna H, Agnarsson BA, Caligo
MA, Olsson H, Kristoffersson U, Liljegren A, Arver B, Karlsson P, Melin B; SWE-BRCA, Sinilnikova OM, McGuffog L,
Antoniou AC, Chenevix-Trench G, Spurdle AB, Couch FJ.
Evidence for SMAD3 as a modifier of breast cancer risk in
BRCA2 mutation carriers.
Breast Cancer Res. 2010 Nov 29;12(6):R102
IF: 5,326
Wang X, Pankratz VS, Fredericksen Z, Tarrell R, Karaus M,
McGuffog L, Pharaoh PD, Ponder BA, Dunning AM, Peock
S, Cook M, Oliver C, Frost D; EMBRACE, Sinilnikova OM,
Stoppa-Lyonnet D, Mazoyer S, Houdayer C; GEMO, Hogervorst FB, Hooning MJ, Ligtenberg MJ; HEBON, Spurdle
A, Chenevix-Trench G; kConFab, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Domchek SM, Nathanson
KL, Rebbeck TR, Singer CF, Gschwantler-Kaulich D,
Dressler C, Fink A, Szabo CI, Zikan M, Foretova L, Claes
K, Thomas G, Hoover RN, Hunter DJ, Chanock SJ, Easton
DF, Antoniou AC, Couch FJ.
Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer
risk in BRCA1 and BRCA2 mutation carriers.
Hum Mol Genet. 2010 Jul 15;19(14):2886-97
IF: 7,386
Domchek SM, Friebel TM, Garber JE, Isaacs C, Matloff E,
Eeles R, Evans DG, Rubinstein W, Singer CF, Rubin S,
Lynch HT, Daly MB, Weitzel J, Ganz PA, Pichert G, Olopade
OI, Tomlinson G, Tung N, Blum JL, Couch F, Rebbeck TR
Occult ovarian cancers identified at risk-reducing salpingooophorectomy in a prospective cohort of BRCA1/2 mutation carriers.
Breast Cancer Res Treat. 2010 Nov;124(1):195-203
IF: 4,696
Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch
HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles
R, Pichert G, Van t‘veer L, Tung N, Weitzel JN, Couch FJ,
Rubinstein WS, Ganz PA, Daly MB, Olopade OI, Tomlinson
G, Schildkraut J, Blum JL, Rebbeck TR.
Association of risk-reducing surgery in BRCA1 or BRCA2
mutation carriers with cancer risk and mortality.
JAMA. 2010 Sep 1;304(9):967-75
IF: 28,899
Kubista B, Klinglmueller F, Bilban M, Pfeiffer M,
Lass R, Giurea A, Funovics PT, Toma C,
Dominkus M, Kotz R, Thalhammer T,
Trieb K, Zettl T, Singer CF
Microarray analysis identifies distinct gene expression profiles associated with histological subtype in human osteosarcoma.
Int Orthop. 2010 Mar 26
IF: 1,825
Sperinde J, Jin X, Banerjee J, Penuel E, Saha A, Diedrich G,
Huang W, Leitzel K, Weidler J, Ali SM, Fuchs EM, Singer CF,
Köstler WJ, Bates M, Parry G, Winslow J, Lipton A.
Quantitation of p95HER2 in paraffin sections by using a
p95-specific antibody and correlation with outcome in a
cohort of trastuzumab-treated breast cancer patients.
Clin Cancer Res. 2010 Aug 15;16(16):4226-35 IF: 6,747
Sonderegger S, Haslinger P, Sabri A, Leisser C,
Otten JV, Fiala C, Knöfler M.
Wingless (Wnt)-3A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt
signaling and protein kinase B/AKT activation.
Endocrinology. 2010 Jan;151(1):211-20
IF: 4,752
Dissertationsbonus(x1.5) IF: 7,131
Petru E, Stummvoll W, Angleitner-Boubenizek L,
Scholl T, Sevelda P, Benedicic C,
Speiser P, Reinthaller A.
A literature review-based clinical guide line on the use of erythropoiesis-stimulating agents (ESA) in the treatment of patients with gynaecologic malignancies and related anaemia.
Geburtsh Frauenheilk. 2010; 70:646-657
IF: 0,354
Stammler-Safar M, Ott J, Weber S, Krampl E
Sexual behaviour of women with twin pregnancies.
Twin Res Hum Genet. 2010 Aug;13(4):383-8
IF: 1,994
Tea MK, Grimm C, Heinz-Peer G, Delancey J, Singer C.
The predictive value of suspicious sonographic
characteristics in atypical cyst-like breast lesions.
Breast. 2010 Oct 27
IF: 2,087
Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF,
Krainer M, Fischer MB, Sehouli J, Reinthaller A,
Horvat R, Heinze G, Tong D, Zeillinger R
Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer
patients.
BMC Cancer. 2010 Dec 3;10(1):666
IF: 2,736
Tong D, Heinze G, Pils D, Wolf A, Singer CF, Concin N,
Hofstetter G, Schiebel I, Rudas M, Zeillinger R.
Gene expression of PMP22 is an independent prognostic factor
for disease-free and overall survival in breast cancer patients.
BMC Cancer. 2010 Dec 15;10:682
IF: 2,736
Gleiss A, Sanchez-Cabo F, Perco P, Tong D, Heinze G.
Adaptive trimmed t-statistics for identifying predominantly
high expression in a microarray experiment.
Stat Med. 2011 Jan 15;30(1):52-61
IF: 1,990
Bartel G, Walch K, Wahrmann M, Pils S, Küssel L,
Polterauer S, Tempfer C, Böhmig GA.
Prevalence and qualitative properties of circulating antihuman leukocyte antigen alloantibodies after pregnancy:
No association with unexplained recurrent miscarriage.
Hum Immunol. 2010 Nov 12
IF: 2,550
Gleicher N, Weghofer A, Lee I, Barad DH.
FMR1 genotype with autoimmunity-associated polycystic
ovary-like phenotype and decreased pregnancy chance.
PLOS One. 2010 Dec;5(12):e15303
IF: 4,351
Gleicher N, Weghofer A, Barad DH.
Anti-Müllerian hormone (AMH) defines, independent of
age, low versus good live-birth chances in women with severely diminished ovarian reserve.
Fertil Steril. 2010 Dec;94(7):2824-7
IF: 3,970
Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS).
Reprod Biol Endocrinol. 2010 Nov; 10(8):140
IF: 2,077
Improvement in diminished ovarian reserve after
dehydroepiandrosterone supplementation.
Reprod Biomed Online. 2010 Sep;21(3):360-5 IF: 2,380
| 185
Can egg donor selection be improved?--A pilot study.
Reprod Biol Endocrinol. 2010 Jun 24;8:76
IF: 2,077
Discordances between follicle stimulating hormone (FSH)
and anti-Müllerian hormone (AMH) in female infertility.
IF: 2,077
Weghofer A, Klein K,
Stammler-Safar M, Worda C,
Barad DH, Husslein P, Gleicher N.
The impact of fetal gender on prematurity in dichorionic
twin gestations after in vitro fertilization.
IF: 2,077
Ovarian reserve determinations suggest new function of
FMR1 (fragile X gene) in regulating ovarian ageing.
Reprod Biomed Online. 2010 Jun;20(6):768-75 IF: 2,380
Effects of race/ethnicity on triple CGG counts in the FMR1
gene in infertile women and egg donors.
Reprod Biomed Online. 2010 Apr;20(4):485-91 IF: 2,380
Wimazal F, Germing U, Kundi M, Nösslinger T,
Blum S, Geissler P, Baumgartner C, Pfeilstöcker M,
Valent P, Sperr WR.
Evaluation of prognostic significance of eosinophilia and
basophilia in a larger cohort of patients with myelodysplastic syndromes (MDS).
Cancer 2010 May; 116(10): 2372-81
IF: 5,238
Sperr WR, Wimazal F, Kundi M, Baumgartner C,
Nösslinger T, Makrai A, Stauder R, Krieger O,
Pfeilstöcker M, Valent P.
Comorbidity as prognostic variable in MDS: comparative
evaluation of the HCT-CI and CCI in a core dataset of 419
patients of the Austrian MDS Study Group.
Ann Oncol. 2010 Jan; 21(1): 114-19
IF: 5,647
Kasper DC, Mechtler TP, Reischer GH, Witt A,
Langgartner M, Pollak A, Herkner KR, Berger A.
The bacterial load of Ureaplasma parvum in amniotic fluid
is correlated with an increased intrauterine inflammatory
response.
Diagn Microbiol Infect Dis. 2010 Jun;67(2):117-21
IF: 2,451
Bodner K, Laubichler P, Kimberger O, Czerwenka K,
Zeillinger R, Bodner-Adler B
Oestrogen and progesterone receptor expression in patients with adenocarcinoma of the uterine cervix and correlation with various clinicopathological parameters.
Anticancer Res. 2010 Apr;30(4):1341-5
IF: 1,428
Costi MP, Zeillinger R.
Drug resistance in ovarian cancer: biomarkers and treatments Highlights from the DROC meeting held in Modena
(Italy) on the 19th and 20th of February 2009. Scientific
topics discussed at the meeting are reported in the present
issue.
IF: 3,733
Olszewski U, Claffey J, Hogan M, Tacke M, Zeillinger R,
Bednarski PJ, Hamilton G.
Anticancer activity and mode of action of titanocene C.
Invest New Drugs. 2010 Feb 17
IF: 3,072
Gundacker C, Fröhlich S, Graf-Rohrmeister K,
Eibenberger B, Jessenig V, Gicic D, Prinz S,
ittmann KJ, Zeisler H, Vallant B, Pollak A, Husslein P
Perinatal lead and mercury exposure in Austria.
Sci Total Environ. 2010 Nov 1;408(23):5744-9 IF: 2,905
Verlohren S, Galindo A, Schlembach D, Zeisler H,
Herraiz I, Moertl MG, Pape J, Dudenhausen JW,
Denk B, Stepan H
An automated method for the determination of the sFlt-1/
PIGF ratio in the assessment of preeclampsia.
Am J Obstet Gynecol. 2010 Feb;202(2):161.e1-161.e11
IF: 3,278
Early Breast Cancer Trialists‘ Collaborative Group (EBCTCG), Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, Peto R, Bijker N, Solin L, Darby S., Singer CF
Overview of the randomized trials of radiotherapy in ductal
carcinoma in situ of the breast.
J Natl Cancer Inst Monogr. 2010;2010(41):162-77
IF: 14,069
Lipton A, Köstler WJ, Leitzel K, Ali SM, Sperinde J, Weidler
J, Paquet A, Sherwood T, Huang W, Bates M; Trastuzumab
Response Biomarker Group. Singer CF
Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab.
Cancer. 2010 Nov 15;116(22):5168-78
IF: 5,418
IMPAKTFAKTOR GESAMT:
IF: 481,556
IMPAKTFAKTOR ERSTAUTOREN:
IF: 124,085
IMPAKTFAKTOR CO-AUTOREN
IF: 357,471

wissenschaftliche publikationen 2010

Transcription

Documents pareils

Dr Elizabeth A. Lobb - The University of Sydney